Dr Sarah McGlasson wins the UK Scopus Early Career Researcher award for Medicine!

Huge congratulations to Dr Sarah McGlasson (UK Dementia Research Institute) who was presented with the UK Scopus Early Career Researcher award for Medicine at an award ceremony on the 4th of October at The Royal Society in London. 

The Scopus Early Career Researcher Award aims to recognize early career researchers who are having a real impact in their chosen field. Sarah was selected for this award by an expert panel of judges based on publication and citation information provided by Scopus, Elsevier’s abstract and citation database.

Dr Sarah McGlasson is a postdoctoral researcher in the lab of Dr David Hunt, in the Dementia Research Institute. The lab is working to understand how innate immune activation leads to neurological damage. 

Sarah’s particular interest is how excessive type I interferon causes damage to cerebral blood vessels, in order to understand how blood vessels become damaged in autoimmune disease such as lupus. Her research uses insights from transgenic models and in vitro work; as well as human disease and clinical data to understand more about the effect of IFN on blood vessels in the brain. 

Ongoing investigations in the lab aim to understand the mechanism of IFN-mediated small vessel damage, identify potential therapeutic targets, and understand whether this process is involved in other diseases with blood vessel damage such as vascular dementia.